Please use this identifier to cite or link to this item:
Title: Immunological changes upon the discontinuation of Hepatitis B antiviral therapy
Keywords: Hepatitis B, HBV, antiviral, Infectious Disease, Immunology, Cytokines
Issue Date: 10-Dec-2014
Citation: MACHTELD VAN DEN BERG (2014-12-10). Immunological changes upon the discontinuation of Hepatitis B antiviral therapy. ScholarBank@NUS Repository.
Abstract: Hepatitis B virus (HBV) is a hepatotropic, non-cytopathic DNA virus that can cause acute or chronic hepatitis. Chronic HBV is commonly transmitted vertically and many patients must engage in long term drug therapy. The long term effects of medical drug therapy are unclear. As a result, there is a need for a clinical detection method which will identify the patients who can safely stop their drug therapy. The aim of this study is to establish an immune profile associated with the development of chronicity and elevated aminotransferase (ALT) levels in response to treatment discontinuation. It is predicted that the adaptive immune response plays a crucial role in determining the development of chronicity versus viral clearance. Both a potent CD4+ t-cell and CD8+ t-cell response is needed. By establishing the type of immune profile associated with the patients who do not develop a hepatic flare upon therapy discontinuation, we will be better able to predict which patients can safely discontinue their treatment.
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Mvandenberg.pdf1.64 MBAdobe PDF



Page view(s)

checked on Feb 8, 2019


checked on Feb 8, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.